Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × Pantoprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Neoplasm Metastasis 2 Zollinger-Ellison Syndrome 1 Vomiting 1 Stomach Neoplasms 1 Spinal Cord Compression 1 Prostatic Neoplasms 1 Pancreatitis 1 Pancreatic Neoplasms 1 Ototoxicity 1 Osteosarcoma 1 Helicobacter Infections 1 Gastritis, Atrophic 1 Gastrinoma 1 Duodenal Neoplasms 1 Delayed Bleeding 1 Breast Neoplasms 1 Advanced Solid Tumours 1

Interventions

Dexamethasone 49 Aprepitant 38 Palonosetron 33 Ondansetron 29 Granisetron 22 Calcium Dobesilate 14 fosaprepitant 13 Olanzapine 13 Therapeutics 8 dexamethasone acetate 7 ramosetron 6 netupitant, palosentron drug combination 6 casopitant 6 Tropisetron 6 Cyclophosphamide 6 dexamethasone 21-phosphate 5 Radiotherapy 5 Metoclopramide 5 Doxorubicin 5 netupitant 4 dolasetron 4 Acupressure 4 Vincristine 3 Tablets 3 Surveys and Questionnaires 3 Prochlorperazine 3 Lorazepam 3 Electroacupuncture 3 Dronabinol 3 Diphenhydramine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948477 2022-05-25

PantoCIN

University of Auckland, New Zealand

Phase 2 Completed

Breast Neoplasms, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡